|
|
 |
| TCTAP 2017 Press Kit |
 |
| TCTAP 2016 Final Program |
|
| Introduction of CVRF |
|
|
 |
|
| TCTAP 2016 Sponsor |
MSD KOREA  |
MSD Korea Ltd. is a Korea corporation of Merck & Co,. Inc as a global health care company. It was established in 1994. We provide great ETC & OTC products & information in Korea.
We make difference in the lives of people globally through our innovative medicines, vaccines, consumer health products
|
8F~ 13F Seoul Credit Guarantee Foundation Building, 168 Gongduk-Dong, Mapo-Gu, Seoul, Korea
+82-2-331-2000
http://www.msd-korea.com
|
Booth No. A005
|
| Lunchtime Activities |
| Benefit of Adding Ezetimibe to Statin Therapy in ACS Patients |
| Organized by CVRF and Supported by Educational Grant from MSD Korea |
Tuesday, April 26
12:45 PM - 1:45 PM
Room 105, Level 1 |
| Moderator(s): Hun Sik Park | | Panelist(s): Sang Yeob Lim | |
| 12:45 PM |
Opening Remark
Speaker : Hun Sik Park
|
| 12:55 PM |
Benefit of Adding Ezetimibe to Statin Therapy in ACS Patients
Lecturer : Sang Yeob Lim
|
| 1:30 PM |
Q & A
|
|
|
|
|
|
